Delivery Order SPE2DB20D2014-SPE2DB24FB54W
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $5.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of $5,107.64 worth of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccines. This delivery order has a completion date of February 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which was not set aside under any specific program. Additionally, AmerisourceBergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a $12,746.62 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-dose vials) on December 1, 2025, with completion targeted for December 2, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs...
- This is a $85,597.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Menveo, a vaccine for meningococcal disease, in 0.5 ml vials. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...
- The Defense Logistics Agency awarded a delivery order valued at $1,206.14 to AmerisourceBergen Drug Corp for Menveo 1 vial (A-C-Y-W-135-DIP, 0.5ML), a meningococcal conjugate vaccine. The contract, awarded December 9, 2025, with completion targeted for December 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has a firm-fixed price of $6,167.73 and an ultimate completion date of September 11, 2024. This award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by various defense and civilian...
- The Defense Logistics Agency awarded a delivery order valued at $3,818.28 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The award, issued on June 16, 2025, with an ultimate completion date of June 17, 2025, represents a firm fixed-price contract with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This delivery order, valued at $1,231.86, awards AmerisourceBergen Drug Corp the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. The contract was awarded by the Defense Logistics Agency (DLA) on June 4, 2025, with an ultimate completion date of June 5, 2025, and represents a firm fixed price arrangement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the MENVEO vaccine in support of military treatment programs. The contract, valued at $39,095.08, has a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. Additionally, Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine product. The $30,442.50 delivery order contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary...